# Treatment options for hereditary ATTR amyloidosis
Treatment of hereditary ATTR amyloidosis aims to slow or stop the harmful protein accumulation and relieve symptoms. In recent years, several medications have been approved that intervene at different points in the disease process. Which treatment is suitable depends on the type of ATTR (nerve form or cardiac form), the stage of the disease, and how far it has progressed.
Transthyretin protein stabilizers
ProveniIncluded in official guidelines, or approved by EMA or FDA
These medications work as a kind of 'stabilizer' for the transthyretin protein in the blood. The normal protein is typically produced in the liver and transports vitamin A and other substances through the body. In hereditary ATTR, however, this protein is malformed due to a mutation and prone to crumble and attach to tissues.
Stabilizers prevent this crumbling by keeping the protein in its correct form. This means there is less malformed protein available for accumulation in nerves, heart, or other organs. Stabilizers can slow the disease process, especially when started at an early stage of the disease.
Known side effects are usually mild and may include headache, nausea, and stomach complaints. Feet and legs may also swell. These symptoms do not occur in everyone and are usually temporary.
Knockdown therapies (RNA inhibitors)
ProveniIncluded in official guidelines, or approved by EMA or FDA
These medications work in the liver, where transthyretin protein is produced. They inhibit the production of the protein, so that less malformed protein enters the blood and therefore less accumulates in the body.
There are two types: antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). ASOs work by neutralizing the message that cells use to make the protein. siRNAs use a similar system. Both are highly effective and can significantly slow or even halt the disease process, especially in early stages.
These medications are usually injected under the skin or into a vein. Side effects depend on the specific substance, but may include inflammatory reactions at the injection site, night sweats, fatigue, and nerve damage. Some people experience fluid buildup. With regular use, laboratory monitoring is needed to monitor kidney and liver function.
These therapies are particularly important for patients in early stages of the disease, because they can prevent or significantly slow progression.
Biological degradation therapies
ResearchediPositive results in clinical studies, not yet standard treatment
These newer approaches aim to remove or break down amyloid protein deposits already in tissues. They work differently than stabilizers or knockdown therapies: they try to address the problem that has already occurred.
One approach uses antibodies that bind to amyloid and thus promote its breakdown. These therapies are in clinical trials and have shown promising results so far, especially for patients with cardiac involvement.
Known side effects from early studies include infusion-related reactions (such as chills and shortness of breath), fatigue, and headache. Research into long-term safety is ongoing.
Supportive treatment of cardiac symptoms
ProveniIncluded in official guidelines, or approved by EMA or FDA
For patients with cardiac amyloidosis, certain medications can help the heart pump better and reduce fluid retention. This includes medications that help regulate blood pressure and combat heart rhythm disorders.
These medications do not act on the amyloid itself, but address its consequences. They are also used for other heart problems and are well researched.
Side effects depend on the specific substance, but may include dizziness, fatigue, and altered electrolyte balance.
Treatment of cardiac arrhythmias
ProveniIncluded in official guidelines, or approved by EMA or FDA
Many patients with ATTR cardiac amyloidosis develop heart rhythm disorders, particularly atrial fibrillation (irregular heartbeat). Medications can stabilize the heart rhythm, or in certain cases catheter techniques (whereby artificial scarring is created in heart tissue along a catheter) can help.
Catheter techniques are a specialized procedure performed in tertiary centers, aimed at redirecting abnormal electrical signals.
Side effects of medications can include electrolyte disturbances; catheter ablation risks include infection, damage to heart walls, and tamponade (filling of the pericardial sac).
Nutrition and swallowing care
ProveniIncluded in official guidelines, or approved by EMA or FDA
For patients with involvement of the esophagus and stomach, dietary adjustments and guidance from a nutrition specialist can help keep food intake safe and comfortable.
This can consist of adapted nutrition (softer, wet, or ground food), speech therapy guidance, and sometimes medical devices. In severe cases, nutritional supplements or artificial nutrition may be necessary.
Side effects do not apply; these are supportive measures.
Neuropathic symptom management
ProveniIncluded in official guidelines, or approved by EMA or FDA
For patients with nerve involvement, medications can help reduce pain, tingling, and other discomforts. These can be painkillers, nerve-strengthening agents, or local therapies (for example patches or ointments).
These treatments do not resolve the underlying amyloid problem, but significantly improve daily comfort.
Known side effects vary by agent and can include dizziness, drowsiness, gastrointestinal complaints, and in rare cases more serious consequences.
Psychological and psychosocial support
ProveniIncluded in official guidelines, or approved by EMA or FDA
Living with a progressive condition can be psychologically burdensome. Guidance from psychologists and social workers helps patients and families process the diagnosis, cope with uncertainty, and plan for the future.
This is not medication treatment, but an essential part of care provision.
Monitoring of the disease and interim adjustments
ProveniIncluded in official guidelines, or approved by EMA or FDA
Regular examinations (blood tests, cardiac imaging, nerve studies) help doctors see how the disease progresses and whether treatment is effective. This can show whether the current treatment plan needs to be adjusted.
For example, doctors can add a stabilizer, switch to a knockdown therapy, or start additional medications for symptoms.
This is part of standard care and has no side effects in itself.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._